La vendita allo scoperto per Scilex Holding dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Scilex Holding. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Scilex Holding (NASDAQ:SCLX) Azioni, Report sulle vendite allo scoperto

SCILEX HOLDING CO

Scilex Holding

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

PDCO

SCLX

Scopri le tre azioni sanitarie più promettenti con un indice RSI basso: un&#39;opportunità di investimento imperdibile per settembre 2024.

3 azioni sanitarie pronte a decollare: è ora di investire?

Scilex Holding Co

WIIM

iPower shares are trading higher after the company announced the formation of United Package NV LLC.

<h3>Gainers</h3>
<ul>
<li>Chegg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) stock moved upwards by 44.6% to $1.75 during Friday's regular session. The market value of their outstanding shares is at $186.4 million. </li>
<li>Rent the Runway (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RENT#NASDAQ">RENT</a>) stock moved upwards by 31.23% to $8.85. The market value of their outstanding shares is at $35.5 million. The company's, Q1 earnings came out yesterday. </li>
<li>iRobot (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRBT#NASDAQ">IRBT</a>) shares moved upwards by 16.56% to $3.9. The company's market cap stands at $119.6 million. </li>
<li>GoPro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GPRO#NASDAQ">GPRO</a>) shares moved upwards by 15.87% to $0.8. The market value of their outstanding shares is at $125.2 million. </li>
<li>QuantaSing Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSG#NASDAQ">QSG</a>) stock rose 15.74% to $6.47. The company's market cap stands at $330.7 million. The company's, Q3 earnings came out today. </li>
<li>Red Robin Gourmet Burgers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRGB#NASDAQ">RRGB</a>) shares increased by 15.15% to $6.99. The market value of their outstanding shares is at $123.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>YSX Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YSXT#NASDAQ">YSXT</a>) stock fell 29.1% to $5.0 during Friday's regular session. The market value of their outstanding shares is at $117.1 million. </li>
<li>Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) shares fell 24.89% to $2.72. The company's market cap stands at $758.5 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Jiade (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JDZG#NASDAQ">JDZG</a>) shares fell 22.13% to $0.27. The market value of their outstanding shares is at $6.5 million. </li>
<li>Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) stock declined by 20.18% to $264.05. The company's market cap stands at $33.0 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>G-III Apparel Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIII#NASDAQ">GIII</a>) shares fell 15.08% to $23.5. The market value of their outstanding shares is at $1.0 billion. As per the news, the Q1 earnings report came out today. </li>
<li>Mullen Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) shares decreased by 13.32% to $7.03. The market value of their outstanding shares is at $3.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

CHGG

GIII

GPRO

IRBT

JDZG

LULU

MULN

RENT

RRGB

WOOF

YSXT

12 Consumer Discretionary Stocks Moving In Friday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Phathom Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAT#NASDAQ">PHAT</a>) stock rose 85.8% to $8.71 during Friday's regular session. The company's market cap stands at $606.9 million. </li>
<li>Know Labs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KNW#AMEX">KNW</a>) shares rose 54.86% to $0.79. The market value of their outstanding shares is at $5.9 million. </li>
<li>Bluejay Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJDX#NASDAQ">BJDX</a>) shares rose 48.68% to $2.26. The market value of their outstanding shares is at $3.3 million. </li>
<li>China SXT Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTC#NASDAQ">SXTC</a>) stock moved upwards by 39.16% to $1.86. The company's market cap stands at $48.5 million. </li>
<li>BioSig Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#NASDAQ">BSGM</a>) stock moved upwards by 38.76% to $7.96. The market value of their outstanding shares is at $217.4 million. </li>
<li>NuCana (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNA#NASDAQ">NCNA</a>) stock moved upwards by 29.87% to $0.05. As per the news, the Q1 earnings report came out 4 days ago. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Vera Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERA#NASDAQ">VERA</a>) shares fell 29.0% to $21.74 during Friday's regular session. The market value of their outstanding shares is at $1.3 billion. </li>
<li>Scinai Immunotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNI#NASDAQ">SCNI</a>) stock fell 24.62% to $2.45. The market value of their outstanding shares is at $2.2 million. </li>
<li>Accuray (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARAY#NASDAQ">ARAY</a>) shares declined by 15.17% to $1.29. The market value of their outstanding shares is at $132.8 million. </li>
<li>Cyclacel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) shares decreased by 15.1% to $0.51. The company's market cap stands at $12.2 million. </li>
<li>Evoke Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOK#NASDAQ">EVOK</a>) shares fell 13.4% to $3.0. The company's market cap stands at $4.4 million. </li>
<li>Nuwellis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) stock declined by 13.39% to $0.53. The market value of their outstanding shares is at $2.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARAY

BJDX

BSGM

CYCC

EVOK

NCNA

NUWE

PHAT

SCNI

SXTC

VERA

12 Health Care Stocks Moving In Friday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>FuelCell Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCEL#NASDAQ">FCEL</a>) shares rose 36.5% to $7.1 during Friday's regular session. The company's market cap stands at $150.1 million. As per the press release, Q2 earnings came out today. </li>
<li>Byrna Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYRN#NASDAQ">BYRN</a>) stock rose 24.16% to $32.99. The market value of their outstanding shares is at $747.7 million. </li>
<li>NET Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPWR#NYSE">NPWR</a>) stock moved upwards by 21.81% to $2.62. The market value of their outstanding shares is at $203.5 million. </li>
<li>Palladyne AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDYN#NASDAQ">PDYN</a>) stock rose 20.83% to $9.95. The market value of their outstanding shares is at $355.1 million. </li>
<li>AgEagle Aerial Sys (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UAVS#AMEX">UAVS</a>) stock rose 17.45% to $1.25. The market value of their outstanding shares is at $17.3 million. </li>
<li>CleanCore Solutions (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ZONE#AMEX">ZONE</a>) stock moved upwards by 17.42% to $4.11. The market value of their outstanding shares is at $32.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Northann (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NCL#AMEX">NCL</a>) shares decreased by 80.0% to $0.27 during Friday's regular session. The company's market cap stands at $14.9 million. </li>
<li>Marwynn Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MWYN#NASDAQ">MWYN</a>) stock declined by 70.29% to $2.93. The market value of their outstanding shares is at $49.9 million. </li>
<li>ATIF Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBAI#NASDAQ">ZBAI</a>) stock declined by 31.4% to $0.49. The company's market cap stands at $8.5 million. </li>
<li>Concrete Pumping Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBCP#NASDAQ">BBCP</a>) stock decreased by 17.64% to $5.84. The company's market cap stands at $309.8 million. As per the news, the Q2 earnings report came out yesterday. </li>
<li>ABM Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABM#NYSE">ABM</a>) stock fell 14.74% to $43.7. The company's market cap stands at $2.7 billion. As per the press release, Q2 earnings came out today. </li>
<li>ZJK Industrial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZJK#NASDAQ">ZJK</a>) stock fell 13.21% to $4.69. The market value of their outstanding shares is at $287.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BBCP

BYRN

FCEL

MWYN

Nuveen Insured California Premium Fund Ii

NPWR

PDYN

UAVS

ZBAI

ZONE

12 Industrials Stocks Moving In Friday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Brand Engagement Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNAI#NASDAQ">BNAI</a>) shares moved upwards by 34.8% to $0.62 during Friday's regular session. The company's market cap stands at $25.7 million. </li>
<li>Unusual Machines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UMAC#AMEX">UMAC</a>) stock rose 29.44% to $8.44. The market value of their outstanding shares is at $209.5 million. </li>
<li>Diginex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGNX#NASDAQ">DGNX</a>) shares increased by 29.41% to $55.0. The company's market cap stands at $1.2 billion. </li>
<li>TSS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSSI#NASDAQ">TSSI</a>) stock rose 18.68% to $20.11. The market value of their outstanding shares is at $503.0 million. </li>
<li>Gorilla Tech Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRRR#NASDAQ">GRRR</a>) stock increased by 17.77% to $22.59. The market value of their outstanding shares is at $417.1 million. </li>
<li>TeraWulf (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WULF#NASDAQ">WULF</a>) stock rose 16.31% to $4.46. The company's market cap stands at $1.7 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Global Engine Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLE#NASDAQ">GLE</a>) stock decreased by 22.2% to $1.59 during Friday's regular session. The company's market cap stands at $29.1 million. </li>
<li>Oblong (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OBLG#NASDAQ">OBLG</a>) stock declined by 18.2% to $3.08. The company's market cap stands at $4.0 million. </li>
<li>Docusign (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) shares fell 17.92% to $76.26. The market value of their outstanding shares is at $15.4 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Next Technology Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXTT#NASDAQ">NXTT</a>) stock declined by 16.67% to $1.35. The company's market cap stands at $588.9 million. </li>
<li>Braze (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) stock decreased by 15.55% to $30.49. The market value of their outstanding shares is at $3.1 billion. The company's, Q1 earnings came out yesterday. </li>
<li>FOXO Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#AMEX">FOXO</a>) stock fell 10.71% to $0.33. The market value of their outstanding shares is at $2.1 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BNAI

BRZE

DGNX

DOCU

FOXO

GRRR

Next Technology Holding Inc. - Ordinary Shares

NXTT

OBLG

TSSI

UMAC

WULF

12 Information Technology Stocks Moving In Friday's Intraday Session

Northland Capital Markets analyst Ted Jackson downgrades Toro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTC#NYSE">TTC</a>) from Outperform to Market Perform and lowers the price target from $100 to $80.

Downgrades

Price Target

Analyst Ratings

Northland Capital Markets Downgrades Toro to Market Perform, Lowers Price Target to $80

Citigroup analyst Filippo Falorni maintains Brown-Forman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>) with a Neutral and lowers the price target from $35 to $28.

BF/B

Citigroup Maintains Neutral on Brown-Forman, Lowers Price Target to $28

Mizuho analyst Vijay Rakesh maintains Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) with a Outperform and raises the price target from $300 to $310.

AVGO

Mizuho Maintains Outperform on Broadcom, Raises Price Target to $310

<figure class="wp-block-image size-large"><img decoding="async" src="https://thearorareport.com/wp-content/uploads/2025/06/2025-06-06_08h41_11.png" alt="" /></figure>
To gain an edge, this is what you need to know today.
<h4 class="wp-block-heading">Buying On Lagging Indicator</h4>
Please <a href="https://thearorareport.com/stock-market-chart-analysis-jobs-report-china-talks-spy-mc-06062025">click here</a> for an enlarged chart of SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) which represents the benchmark stock market index S&amp;P 500 (SPX).
Note the following:
<ul class="wp-block-list">
<li>The chart shows the stock market remains below zone 1 (resistance).</li>
<li>RSI on the chart shows the stock market is now overbought.&nbsp; It still has room to run, but could also pullback.</li>
<li>Zone 1 is the magnet for the momo crowd.&nbsp; As of this writing, the momo crowd is aggressively buying stocks, trying to push the stock market to the magnet.</li>
<li>Wall Street is jubilant that a new high is in sight.</li>
<li>Yesterday, Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) stock fell 14.26% as the breakup between President Trump and First Buddy Elon Musk played out in public.&nbsp; Overnight, TSLA stock saw aggressive buying on indications that both President Trump and Musk might be open to a truce.</li>
<li>The Trump-Musk acrimony had a significant negative impact on the entire stock market yesterday.  This morning, the stock market has forgotten it all.  In our analysis, considering that Musk said that President Trump was in the Epstein files and endorsed President Trump's impeachment, it will be very difficult to rebuild the relationship.</li>
<li>The phone call between President Trump and President Xi of China brought in buying in the stock market.&nbsp; Chinese media is reporting that President Xi lectured President Trump on how the U.S. should behave.&nbsp; There is jubilation in China and a claim of President Xi's victory over President Trump.&nbsp; There is no confirmation or denial from the U.S. side.</li>
<li>Microsoft Corp (MSFT) stock hit an all time high.  As full disclosure, MSFT was one of the stocks we recommended to buy on April 9 when it was at $369.50.  Since then, MSFT stock is up 26.6%.</li>
<li>The jobs report was stronger than expected.&nbsp; Here are the details: 
<ul class="wp-block-list">
<li>Non-farm payrolls came at 139K vs. 130K consensus.</li>
<li>Non-farm private payrolls came at 140K vs. 123K consensus.</li>
<li>Unemployment rate came at 4.2% vs. 4.2% consensus.</li>
<li>Average work week came at 34.3 vs. 34.3 consensus.</li>
<li>Average hourly earnings came at 0.4% vs. 0.3% consensus.</li>
</ul>
</li>
<li>Even though there is aggressive buying on the jobs report, in our analysis, prudent investors should consider the following: 
<ul class="wp-block-list">
<li>The jobs report is a lagging indicator.&nbsp;&nbsp;</li>
<li>The jobs report historically stays strong all the way to the start of a recession and then falls quickly.</li>
<li>The best way to understand this is to think of a steep fall off of a cliff.&nbsp;&nbsp;</li>
<li>Our adaptive <a href="https://thearorareport.com/ALLOCATION%2BMODELS.htm">ZYX Asset Allocation Model </a>is based on leading indicators.  </li>
</ul>
</li>
<li>In our analysis, prudent investors should also pay attention to rising bond yields this morning after the jobs report even though the market is oblivious so far.</li>
<li>Of importance to the AI trade is that Broadcom Inc (AVGO) reported solid earnings inline with consensus but below whisper numbers.  Normally, a stock like AVGO goes down if it reports less than whisper numbers.  So far as of this writing, AVGO is only down about only 3% due to extreme bullishness that is prevailing in the stock market.</li>
<li>Lululemon Athletica Inc (LULU) reported earnings inline with consensus but below whisper numbers.  Lululemon also cut guidance.  LULU stock is down over 18% as of this writing.  Lululemon earnings are often an indication of the high end consumer.  However, the guidance cut seems to be driven by tariffs and Chinese consumers, not the U.S. consumer.</li>
</ul>
<h4 class="wp-block-heading">Europe</h4>
Stronger than expected GDP in the Eurozone is adding to bullishness in the stock market. Eurozone GDP came at 0.6% quarter-over-quarter vs. 0.3% consensus.
<h4 class="wp-block-heading">Magnificent Seven Money Flows</h4>
In the early trade, money flows are positive in Apple Inc (AAPL), Amazon.com, Inc. (AMZN), Alphabet Inc Class C ( GOOG), Meta Platforms Inc (META), Microsoft Corp (MSFT), NVIDIA Corp (NVDA), and TSLA.
In the early trade, money flows are positive in S&amp;P 500 ETF (SPY) and in Invesco QQQ Trust Series 1 (QQQ).
<h4 class="wp-block-heading">Momo Crowd And Smart Money In Stocks</h4>
Investors can gain an edge by knowing money flows in SPY and QQQ.  Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.  The most popular ETF for gold is SPDR Gold Trust (GLD).  The most popular ETF for silver is iShares Silver Trust (SLV).  The most popular ETF for oil is United States Oil ETF (USO).
<h4 class="wp-block-heading">Bitcoin</h4>
Bitcoin is range bound.
<h4 class="wp-block-heading">Arora Protection Band And What To Do Now</h4>
It is important for investors to look ahead and not in the rearview mirror.  Our proprietary Protection Band puts all of the data, all of the indicators, all of the news, all of the crosscurrents, all of the models, and all of the analysis in an analytical framework that is easily actionable by investors.
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp; The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp; If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp; A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp; When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp; High beta stocks are the ones that move more than the market.
<h4 class="wp-block-heading">Traditional 60/40 Portfolio</h4>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.&nbsp; Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.
The Arora Report is known for its accurate calls. The Arora Report correctly called the big artificial intelligence rally before anyone else, the new bull market of 2023, the bear market of 2022, new stock market highs right after the virus low in 2020, the virus drop in 2020, the DJIA rally to 30,000 when it was trading at 16,000, the start of a mega bull market in 2009, and the financial crash of 2008. Please click here to sign up for a free forever <a href="https://thearorareport.com/generate-wealth-newsletter-benzinga">Generate Wealth Newsletter</a>.

Equities

Market Summary

Broad U.S. Equity ETFs

Opinion

TSLA

Tesla Bounces On Musk-Trump Truce Talk; Aggressive Buying On Jobs Report - A Lagging Indicator

Financial giants have made a conspicuous bullish move on Shopify. Our analysis of options history for Shopify (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NASDAQ">SHOP</a>) revealed 29 unusual trades.
Delving into the details, we found 51% of traders were bullish, while 34% showed bearish tendencies. Out of all the trades we spotted, 8 were puts, with a value of $561,625, and 21 were calls, valued at $1,026,308.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $55.0 to $190.0 for Shopify over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for Shopify options trades today is 1649.52 with a total volume of 6,361.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Shopify's big money trades within a strike price range of $55.0 to $190.0 over the last 30 days.
<h3>Shopify Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749229393_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SHOP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$2.76</td>
<td>$2.61</td>
<td>$2.69</td>
<td>$105.00</td>
<td>$182.4K</td>
<td>2.9K</td>
<td align="right">722</td>
</tr>
<tr>
<td>SHOP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$29.55</td>
<td>$29.2</td>
<td>$29.26</td>
<td>$125.00</td>
<td>$119.9K</td>
<td>26</td>
<td align="right">47</td>
</tr>
<tr>
<td>SHOP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$16.65</td>
<td>$16.45</td>
<td>$16.45</td>
<td>$100.00</td>
<td>$101.9K</td>
<td>129</td>
<td align="right">74</td>
</tr>
<tr>
<td>SHOP</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$32.8</td>
<td>$32.6</td>
<td>$32.62</td>
<td>$85.00</td>
<td>$97.8K</td>
<td>2.0K</td>
<td align="right">32</td>
</tr>
<tr>
<td>SHOP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$9.2</td>
<td>$9.05</td>
<td>$9.05</td>
<td>$135.00</td>
<td>$95.0K</td>
<td>3.5K</td>
<td align="right">109</td>
</tr>
</tbody>
</table>

<h3>About Shopify</h3>
Shopify offers an e-commerce platform primarily to small and medium-size businesses. The firm has two segments. The subscription solutions segment allows Shopify merchants to conduct e-commerce on a variety of platforms, including the company's website, physical stores, pop-up stores, kiosks, social networks (Facebook), and Amazon. The merchant solutions segment offers add-on products for the platform that facilitate e-commerce and include Shopify Payments, Shopify Shipping, and Shopify Capital.
Having examined the options trading patterns of Shopify, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Shopify Standing Right Now?</h3>
<ul>
<li>With a trading volume of 4,706,835, the price of SHOP is up by 5.73%, reaching $111.04.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 61 days from now.</li>
</ul>
<h3>Expert Opinions on Shopify</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $111.2.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Morgan Stanley continues to hold a Overweight rating for Shopify, targeting a price of $112. 
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Neutral rating on Shopify with a target price of $110. 
&#x2A; An analyst from Barclays persists with their Equal-Weight rating on Shopify, maintaining a target price of $94. 
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on Shopify with a target price of $125. 
&#x2A; An analyst from JP Morgan has decided to maintain their Overweight rating on Shopify, which currently sits at a price target of $115. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Shopify, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

SHOP

Market Whales and Their Recent Bets on SHOP Options

Macro Economic Events

Econ #s

Economics

U.S. Baker Hughes Oil Rig Count Down -9 To 442; U.S. Baker Hughes NatGas Rig Count +5 To 114; U.S. Baker Hughes Total Rig Count 559 Vs 563	Prior

Investors with a lot of money to spend have taken a bearish stance on Royal Caribbean Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with RCL, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 12 uncommon options trades for Royal Caribbean Gr.
This isn't normal.
The overall sentiment of these big-money traders is split between 33% bullish and 58%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $166,703, and 9 are calls, for a total amount of $750,895.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $130.0 and $330.0 for Royal Caribbean Gr, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Royal Caribbean Gr options trades today is 445.27 with a total volume of 590.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Royal Caribbean Gr's big money trades within a strike price range of $130.0 to $330.0 over the last 30 days.
<h3>Royal Caribbean Gr 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749229388_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>RCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$140.4</td>
<td>$139.0</td>
<td>$140.39</td>
<td>$140.00</td>
<td>$280.7K</td>
<td>54</td>
<td align="right">20</td>
</tr>
<tr>
<td>RCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$31.5</td>
<td>$31.0</td>
<td>$31.0</td>
<td>$250.00</td>
<td>$235.4K</td>
<td>952</td>
<td align="right">78</td>
</tr>
<tr>
<td>RCL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$11.65</td>
<td>$11.5</td>
<td>$11.5</td>
<td>$260.00</td>
<td>$115.0K</td>
<td>284</td>
<td align="right">109</td>
</tr>
<tr>
<td>RCL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$145.2</td>
<td>$144.25</td>
<td>$144.25</td>
<td>$130.00</td>
<td>$43.2K</td>
<td>3</td>
<td align="right">5</td>
</tr>
<tr>
<td>RCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/06/25</td>
<td>$4.3</td>
<td>$2.8</td>
<td>$2.91</td>
<td>$272.50</td>
<td>$39.5K</td>
<td>2.3K</td>
<td align="right">136</td>
</tr>
</tbody>
</table>

<h3>About Royal Caribbean Gr</h3>
Royal Caribbean is the world's second-largest cruise company by revenues, operating 67 ships across five global and partner brands in the cruise vacation industry. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises. The selection of brands in the portfolio allows Royal to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in 2021 and plans to launch its new Celebrity River Cruise brand in 2027.
In light of the recent options history for Royal Caribbean Gr, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Royal Caribbean Gr's Current Market Status</h3>
<ul>
<li>With a trading volume of 881,919, the price of RCL is up by 1.44%, reaching $275.3.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 48 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Royal Caribbean Gr</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $298.8.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Macquarie persists with their Outperform rating on Royal Caribbean Gr, maintaining a target price of $265. 
&#x2A; Maintaining their stance, an analyst from Citigroup continues to hold a Buy rating for Royal Caribbean Gr, targeting a price of $318. 
&#x2A; An analyst from Stifel has decided to maintain their Buy rating on Royal Caribbean Gr, which currently sits at a price target of $310. 
&#x2A; An analyst from UBS persists with their Buy rating on Royal Caribbean Gr, maintaining a target price of $311. 
&#x2A; Consistent in their evaluation, an analyst from Loop Capital keeps a Buy rating on Royal Caribbean Gr with a target price of $290. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Royal Caribbean Gr, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

What the Options Market Tells Us About Royal Caribbean Gr

Whales with a lot of money to spend have taken a noticeably bearish stance on Chevron.
Looking at options history for Chevron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 37% of the investors opened trades with bullish expectations and 62% with bearish.
From the overall spotted trades, 4 are puts, for a total amount of $170,833 and 4, calls, for a total amount of $237,771.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $110.0 to $150.0 for Chevron over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Chevron's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Chevron's significant trades, within a strike price range of $110.0 to $150.0, over the past month.
<h3>Chevron Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749229382_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$22.1</td>
<td>$21.85</td>
<td>$22.1</td>
<td>$130.00</td>
<td>$110.5K</td>
<td>482</td>
<td align="right">51</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/13/25</td>
<td>$1.87</td>
<td>$1.86</td>
<td>$1.87</td>
<td>$140.00</td>
<td>$66.0K</td>
<td>939</td>
<td align="right">994</td>
</tr>
<tr>
<td>CVX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$5.85</td>
<td>$5.75</td>
<td>$5.85</td>
<td>$140.00</td>
<td>$47.9K</td>
<td>4.2K</td>
<td align="right">108</td>
</tr>
<tr>
<td>CVX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$12.4</td>
<td>$11.95</td>
<td>$11.95</td>
<td>$150.00</td>
<td>$45.4K</td>
<td>2.0K</td>
<td align="right">38</td>
</tr>
<tr>
<td>CVX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$4.5</td>
<td>$4.4</td>
<td>$4.5</td>
<td>$110.00</td>
<td>$44.0K</td>
<td>469</td>
<td align="right">1</td>
</tr>
</tbody>
</table>

<h3>About Chevron</h3>
Chevron is an integrated energy company with exploration, production, and refining operations worldwide. It is the second-largest oil company in the United States with production of 3.0 million of barrels of oil equivalent a day, including 7.7 million cubic feet a day of natural gas and 1.7 million of barrels of liquids a day. Production activities take place in North America, South America, Europe, Africa, Asia, and Australia. Its refineries are in the US and Asia for total refining capacity of 1.8 million barrels of oil a day. Proven reserves at year-end 2024 stood at 9.8 billion barrels of oil equivalent, including 5.1 billion barrels of liquids and 28.4 trillion cubic feet of natural gas.
Following our analysis of the options activities associated with Chevron, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Chevron</h3>
<ul>
<li>Currently trading with a volume of 3,076,481, the CVX's price is up by 2.45%, now at $140.26. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 56 days.</li>
</ul>
<h3>Expert Opinions on Chevron</h3>
3 market experts have recently issued ratings for this stock, with a consensus target price of $168.67.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from HSBC downgraded its action to Hold with a price target of $158. 
&#x2A; An analyst from Mizuho has decided to maintain their Outperform rating on Chevron, which currently sits at a price target of $186. 
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Overweight rating for Chevron, targeting a price of $162. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Chevron, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Decoding Chevron's Options Activity: What's the Big Picture?

QuantaSing Group shares are trading higher. The company reported Q3 financial results.

AMZN

CNBC Halftime Report Final Trades: Amazon, Jefferies Financial Group, e.l.f. Beauty, Ventas

Citigroup analyst Steven Enders maintains Pegasystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGA#NASDAQ">PEGA</a>) with a Buy and raises the price target from $116 to $131.

PEGA

Citigroup Maintains Buy on Pegasystems, Raises Price Target to $131

GlycoMimetics's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLYC#NYSE">GLYC</a>) short percent of float has fallen 8.14% since its last report. The company recently reported that it has 1.68 million shares sold short, which is 3.16% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.71 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>GlycoMimetics Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749229230_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for GlycoMimetics has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing GlycoMimetics's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, GlycoMimetics's peer group average for short interest as a percentage of float is 2.98%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

GLYC

What Does the Market Think About GlycoMimetics?

APA's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APA#NYSE">APA</a>) short percent of float has risen 12.23% since its last report. The company recently reported that it has 40.45 million shares sold short, which is 12.76% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.35 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>APA Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749229225_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for APA has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing APA's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, APA's peer group average for short interest as a percentage of float is 8.05%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is APA Gaining or Losing Market Support?

In the current market session, RTX Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) stock price is at $138.76, after a 0.22% drop. However, over the past month, the company's stock spiked by 7.85%, and in the past year, by 29.58%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1749229223_0.png" alt="Past Year Chart" />

<h3>Evaluating RTX P/E in Comparison to Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
RTX has a lower P/E than the aggregate P/E of 120.38 of the Aerospace &amp; Defense industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1749229223_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

A Look Into RTX Inc's Price Over Earnings

Albemarle's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) short percent of float has risen 10.43% since its last report. The company recently reported that it has 18.83 million shares sold short, which is 24.14% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.73 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Albemarle Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749229219_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Albemarle has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Albemarle's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Albemarle's peer group average for short interest as a percentage of float is 3.68%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Albemarle?

Press Releases

Scilex Holding Company Announces 1-for-35 Reverse Stock Split

Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination

Health Care

General

Scilex Holding Company Announces Approval of a New Drug Submission (NDS) from the Health Canada's Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for ELYXYB®'s Acute Treatment of Migraine With or Without Aura in Canada

Scilex Holding Company Announces FDA Has Approved Our Request for the Orphan Drug Designation for Colchicine for the Treatment of Pericarditis

Dividends

Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from April 11, 2025 to May 2, 2025

Scilex Holding Company Regains Compliance with NASDAQ Minimum Bid Price Rule

Scilex Holding Company to Present Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of Interventional Pain Physicians (ASIPP), May 15-17, 2025 in Orlando, FL.

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

Scilex Holding Company Presented Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of Interventional Pain Physicians (ASIPP), May 15-17, 2025 in Orlando, FL

Scilex Holding Company Announces Publication on GLOPERBA® Dosing Adjustments in Peer-Review Journal

DECA

SCLXW

Anebulo Pharmaceuticals, Inc. - Common Stock

Anebulo Pharmaceuticals

AN2 Therapeutics

Assertio Holdings

CalciMedica

Cingulate

Clearside Biomedical, Inc. - Common Stock

Clearside Biomedical

Context Therapeutics

Cadrenal Therapeutics, Inc. - Common Stock

Cadrenal Therapeutics

Dare Bioscience

Grace Therapeutics

IGC Pharma

Ikena Oncology

Iterum Therapeutics

Jupiter Neurosciences, Inc. - Common Stock

Jupiter Neurosciences

Lyra Therapeutics

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals

NRX Pharmaceuticals

Pulmatrix

Rafael Holdings, Inc. Class B Common Stock

Rafael Holdings

Relmada Therapeutics, Inc. - Common Stock

Relmada Therapeutics

Reviva Pharmaceuticals Holdings, Inc. - Common Stock

Reviva Pharmaceuticals

SCYNEXIS

China SXT Pharmaceuticals, Inc. - Common Stock

China SXT Pharmaceuticals

Telomir Pharmaceuticals, Inc. - Common Stock

Telomir Pharmaceuticals

Verrica Pharmaceuticals Inc. - Common Stock

Verrica Pharmaceuticals

HC Wainwright & Co.

Alliance Global Partners

Rodman & Renshaw

B. Riley Securities

Semnur Pharmaceuticals, Inc., A Wholly Owned Subsidiary Of Scilex Holding Company, Announces Today The Filing Of A Registration Statement On Form S-4 by Denali Capital Acquisition Corp. With The Securities And Exchange Commission Relating To The Previously Announced Proposed Business Combination Between Semnur And Denali

Skyscrapers,Cityscape,Downtown,View,,Nashville,Skyline,Buildings.,Beautiful,Real,Estate.

Scilex Holding Company Announces Signing Of A $50 Million Registered Convertible Financing To Refinance And Restructure Existing Debt &amp; Further Strengthens Financial Profile

United,States,Bankruptcy,Court,Sign

Biotech

SRNEQ

Scilex Holding Company Announces That The U.S. Bankruptcy Court Has Extended The Lockup Period On Shares Of Scilex Dividend Stock Previously Distributed By Sorrento To Its Stockholders As A Dividend To January 31, 2025

Business,Analyst,Checking,In,Financial,Statement,For,Audit,Internal,Control

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Month Ended July 31, 2024

Hand,Of,Human,Holding,Crystal,Globe,Ball,With,Tree,For

Scilex Holding Company Announces Publication of Its Inaugural Sustainability Report

Business,Man,Sign,A,Contract,Investment,Professional,Document,Agreement.,Meeting

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination

Businessmen,Making,Handshake,With,Partner,,Greeting,,Dealing,,Merger,And,Acquisition,

Scilex Holding Company Partners With New National Distributor, Endeavor Distribution LLC.

Muscular,Man,Suffering,From,Back,And,Neck,Pain.,Incorrect,Sitting

Scilex Holding Company Announces Publication In PAIN Journal Regarding Phase 3 Results Of The Pivotal Registration Trial Of SP-102 (SEMDEXA™) In Lumbosacral Radicular Pain (Sciatica)

Outside,Of,Logistics,Warehouse,With,Open,Door,,Delivery,Van,Loaded

Scilex Holding Company Announces That Many National Pharmacy Chains And Independent Pharmacies Have Begun Stocking GLOPERBA®

Interior,Of,A,Modern,Warehouse,Storage,Of,Retail,Shop,With

Scilex Holding Company Announces Stocking Of GLOPERBA® Is Underway In All Of The Wholesalers With Which Scilex Has Stocking Arrangements Throughout The U.S.

Comments

Scilex Holding

Vendite allo scoperto

Scilex Holding (NASDAQ:SCLX) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO